These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38949991)

  • 1. Combinatorial actions of IL-22 and IL-17 drive optimal immunity to oral candidiasis through SPRRs.
    Aggor FEY; Bertolini M; Coleman BM; Taylor TC; Ponde NO; Gaffen SL
    PLoS Pathog; 2024 Jul; 20(7):e1012302. PubMed ID: 38949991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of neutrophils in IL-17-dependent immunity to mucosal candidiasis.
    Huppler AR; Conti HR; Hernández-Santos N; Darville T; Biswas PS; Gaffen SL
    J Immunol; 2014 Feb; 192(4):1745-52. PubMed ID: 24442441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral epithelial IL-22/STAT3 signaling licenses IL-17-mediated immunity to oral mucosal candidiasis.
    Aggor FEY; Break TJ; Trevejo-Nuñez G; Whibley N; Coleman BM; Bailey RD; Kaplan DH; Naglik JR; Shan W; Shetty AC; McCracken C; Durum SK; Biswas PS; Bruno VM; Kolls JK; Lionakis MS; Gaffen SL
    Sci Immunol; 2020 Jun; 5(48):. PubMed ID: 32503875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-17-induced protein lipocalin 2 is dispensable for immunity to oral candidiasis.
    Ferreira MC; Whibley N; Mamo AJ; Siebenlist U; Chan YR; Gaffen SL
    Infect Immun; 2014 Mar; 82(3):1030-5. PubMed ID: 24343647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis.
    Conti HR; Shen F; Nayyar N; Stocum E; Sun JN; Lindemann MJ; Ho AW; Hai JH; Yu JJ; Jung JW; Filler SG; Masso-Welch P; Edgerton M; Gaffen SL
    J Exp Med; 2009 Feb; 206(2):299-311. PubMed ID: 19204111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody blockade of IL-17 family cytokines in immunity to acute murine oral mucosal candidiasis.
    Whibley N; Tritto E; Traggiai E; Kolbinger F; Moulin P; Brees D; Coleman BM; Mamo AJ; Garg AV; Jaycox JR; Siebenlist U; Kammüller M; Gaffen SL
    J Leukoc Biol; 2016 Jun; 99(6):1153-64. PubMed ID: 26729813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Interleukin (IL) 17R/IL-22R Signaling Axis Is Dispensable for Vulvovaginal Candidiasis Regardless of Estrogen Status.
    Peters BM; Coleman BM; Willems HME; Barker KS; Aggor FEY; Cipolla E; Verma AH; Bishu S; Huppler AH; Bruno VM; Gaffen SL
    J Infect Dis; 2020 Apr; 221(9):1554-1563. PubMed ID: 31805183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective IL-17- and IL-22-dependent mucosal host response to Candida albicans determines susceptibility to oral candidiasis in mice expressing the HIV-1 transgene.
    Goupil M; Cousineau-Côté V; Aumont F; Sénéchal S; Gaboury L; Hanna Z; Jolicoeur P; de Repentigny L
    BMC Immunol; 2014 Oct; 15():49. PubMed ID: 25344377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-17 Receptor Signaling in Oral Epithelial Cells Is Critical for Protection against Oropharyngeal Candidiasis.
    Conti HR; Bruno VM; Childs EE; Daugherty S; Hunter JP; Mengesha BG; Saevig DL; Hendricks MR; Coleman BM; Brane L; Solis N; Cruz JA; Verma AH; Garg AV; Hise AG; Richardson JP; Naglik JR; Filler SG; Kolls JK; Sinha S; Gaffen SL
    Cell Host Microbe; 2016 Nov; 20(5):606-617. PubMed ID: 27923704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-22 defines a novel immune pathway of antifungal resistance.
    De Luca A; Zelante T; D'Angelo C; Zagarella S; Fallarino F; Spreca A; Iannitti RG; Bonifazi P; Renauld JC; Bistoni F; Puccetti P; Romani L
    Mucosal Immunol; 2010 Jul; 3(4):361-73. PubMed ID: 20445503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The adaptor CARD9 is required for adaptive but not innate immunity to oral mucosal Candida albicans infections.
    Bishu S; Hernández-Santos N; Simpson-Abelson MR; Huppler AR; Conti HR; Ghilardi N; Mamo AJ; Gaffen SL
    Infect Immun; 2014 Mar; 82(3):1173-80. PubMed ID: 24379290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of IL-17A in preventing the development of deep-seated candidiasis from oropharyngeal infection.
    Mosci P; Gabrielli E; Luciano E; Perito S; Cassone A; Pericolini E; Vecchiarelli A
    Microbes Infect; 2014 Aug; 16(8):678-89. PubMed ID: 24980544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signaling through IL-17C/IL-17RE is dispensable for immunity to systemic, oral and cutaneous candidiasis.
    Conti HR; Whibley N; Coleman BM; Garg AV; Jaycox JR; Gaffen SL
    PLoS One; 2015; 10(4):e0122807. PubMed ID: 25849644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-22 neutralizing autoantibodies impair fungal clearance in murine oropharyngeal candidiasis model.
    Bichele R; Kärner J; Truusalu K; Smidt I; Mändar R; Conti HR; Gaffen SL; Peterson P; Laan M; Kisand K
    Eur J Immunol; 2018 Mar; 48(3):464-470. PubMed ID: 29150834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral-resident natural Th17 cells and γδ T cells control opportunistic Candida albicans infections.
    Conti HR; Peterson AC; Brane L; Huppler AR; Hernández-Santos N; Whibley N; Garg AV; Simpson-Abelson MR; Gibson GA; Mamo AJ; Osborne LC; Bishu S; Ghilardi N; Siebenlist U; Watkins SC; Artis D; McGeachy MJ; Gaffen SL
    J Exp Med; 2014 Sep; 211(10):2075-84. PubMed ID: 25200028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early activation of the interleukin-23-17 axis in a murine model of oropharyngeal candidiasis.
    Saunus JM; Wagner SA; Matias MA; Hu Y; Zaini ZM; Farah CS
    Mol Oral Microbiol; 2010 Oct; 25(5):343-56. PubMed ID: 20883223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Th17 cells confer long-term adaptive immunity to oral mucosal Candida albicans infections.
    Hernández-Santos N; Huppler AR; Peterson AC; Khader SA; McKenna KC; Gaffen SL
    Mucosal Immunol; 2013 Sep; 6(5):900-10. PubMed ID: 23250275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C/EBPβ Promotes Immunity to Oral Candidiasis through Regulation of β-Defensins.
    Simpson-Abelson MR; Childs EE; Ferreira MC; Bishu S; Conti HR; Gaffen SL
    PLoS One; 2015; 10(8):e0136538. PubMed ID: 26317211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Langerin+ DCs regulate innate IL-17 production in the oral mucosa during Candida albicans-mediated infection.
    Sparber F; Dolowschiak T; Mertens S; Lauener L; Clausen BE; Joller N; Stoitzner P; Tussiwand R; LeibundGut-Landmann S
    PLoS Pathog; 2018 May; 14(5):e1007069. PubMed ID: 29782555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-17-mediated antifungal defense in the oral mucosa is independent of neutrophils.
    Trautwein-Weidner K; Gladiator A; Nur S; Diethelm P; LeibundGut-Landmann S
    Mucosal Immunol; 2015 Mar; 8(2):221-31. PubMed ID: 25005360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.